News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Sana Biotechnology sets sights on growth after $587.5M IPO
Following a banner year for Sana Biotechnology, which saw the company bring in one of the largest IPOs in biotech history, CEO Steve Harr is

New accelerator in Seattle: Creative Destruction Lab to launch ‘deep tech’ startup hub with Microsoft, UW
Creative Destruction Lab, a nonprofit that runs nine startup accelerators across the world, is opening a new outpost in Seattle. The 9-month program, set to

Bristol Myers “dual immunotherapy” beats Opdivo alone in melanoma study
Bristol Myers Squibb reported promising news on its experimental cancer immunotherapy relatlimab after late-stage clinical data showed that when combined with the company’s blockbuster drug

Seattle company launches coronavirus vaccine trial in India
HDT Bio, a Seattle-based biotech company, is taking steps to address rising COVID-19 cases in India by introducing a new vaccine candidate that works similar

Grandson of Jonas Salk raises cash to find ‘genetic needles in the haystack’
Seattle gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round, bringing its total funding to $70 million. The company, which spun out

New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research
A new lab has launched at the Fred Hutchinson Cancer Research Center to facilitate the cryogenic electron microscopy (cryo-EM) technique, which uses extreme temperatures and

Prevencio links with Atlas Genomics to roll out AI-powered blood tests for heart disease
Prevencio, a Kirkland, Washington-based biotechnology company, will partner with Atlas Genomics’ molecular diagnostic laboratory in Seattle to support the commercial rollout of Prevencio’s HART blood

Medical device startup Nanodropper raises $1.4M for eye drop bottle adapter
Nanodropper, a medical device startup founded by University of Washington and Seattle University graduates, announced that it received $1.4 million in seed funding. The company’s

Meet the most innovative and inventive pharmaceutical companies of 2021
Three life science companies with ties to Seattle were named to Fortune’s list of the 2021 most innovative and inventive pharmaceutical companies, which highlights companies

Oxford continues life sciences expansion with $119M Seattle buy
A Seattle office building was acquired by Toronto-based Oxford Properties Group, which intends to convert it into a fully dedicated life science facility. The purchase

Bothell’s biotech real estate market stays hot with $53M campus sale
Partners Rialto Capital of Miami and SteelWave LLC have bought Bothell-based Highlands Campus Tech Centre, home to Seagen, a leading biotech company that reported a

UW spinout Icosavax raises $100M for vaccine development
Icosavax Inc., a biotech company focused on vaccine development, announced a $100M Series B investment round. Icosavax, a spinout from the University of Washington plans
